View in browser


Pharmaceutical Technology

 
Share this newsletter with a friend or colleague
 
EC grants approval to BMS’ Opdivo combo for gastroesophageal cancer 
image_alt
In a Phase III trial, Opdivo plus chemotherapy offered statistically significant improvement in overall survival.
Inovio signs MoU with Colombia to boost efforts to tackle Covid-19 
image_alt

The MoU will aid in creating production expertise for Inovio’s DNA drugs and technologies in the country.

Pfizer and BioNTech unveil postive data of Covid-19 booster shot trial
image_alt

The efficacy of the booster dose of vaccine was consistent regardless of race, ethnicity, age, sex or comorbid conditions.

Biotage signs agreement to acquire UK’s ATDBio
image_alt

Merging ATDBio’s oligonucleotide production skills with the one-stop-shop customer workflow of Biotage offers high potential. 

UK government secures two Covid-19 antivirals ahead of winter
image_alt

The purchase of Merck and Pfizer’s Covid-19 pills comes as coronavirus cases and hospitalisations rise across the country.


Feature

Merck's molnupiravir: Covid-19 gamechanger status relies on patient risk factors
Molnupiravir access may depend on how risk factors are interpreted but availability could be wider with the help of pharmacists


From our partners


Press Release

Single Use Support Providing Solutions for Gene Therapies
Biopharma solution provider Single Use Support announces an order from Genezen, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO).

Pharmapack 2021: Gerresheimer with Innovative SensAIR Platform for a Drug Delivery Device for Biologics
With SensAIR, Gerresheimer presents an innovative platform for on-body drug delivery which can deliver drugs of higher viscosity, such as monoclonal antibodies (mAb). The aim is to provide patients with the best possible support in the subcutaneous delivery of large-volume biologics.

A Novel Analgesic Peptide Drug has Passed its Pre-clinical Research Phase
The pre-clinical research of a new analgesic peptide drug, which is the largest single-funded project in Hainan Province and lasted for five years has finally been completed successfully by the cooperation of the leading organization Hainan University, the Institute of Toxicology and Drugs of the Military Academy of Sciences, and the company GL Biochem (Shanghai) Ltd, who overcame various difficulties and challenges during the five years.


White Papers

Peptides and Reagents for Peptide Synthesis and Combinatorial Chemistry
GL Biochem (Shanghai) Ltd has an excellent R&D environment with full access to most modern and sophisticated facilities, and equipment necessary for the custom organic or peptide manufacturing.

Scalability Guide – How to Achieve Scalable Freezing & Thawing of Biopharmaceuticals
Scalability around freezing means the ability to guarantee constant stress on proteins (biopharmaceutical molecules) in all scales, filling volumes and loading scenarios.

Challenges in Bulk Drug Substance Logistics
You might think that the final liquid drug substance will be filled into vials at the same location. This is not the case.

Thanks for reading. If you enjoyed this newsletter, please share with colleagues, friends and anybody else, get them to sign up and join the conversation. You can contact us at marketing@verdict.co.uk.

Pharmaceutical Technology